Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline forms of cabozantinib phosphate and cabozantinib hydrochloride

Crystalline forms of cabozantinib phosphate and cabozantinib hydrochloride

US Patent 10053427 · Granted Aug 21, 2018

Estimated economic value: $18,594,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Co-crystals comprising levothyroxine and a dicarboxylic acid2024
Multi-component crystals of an orally available HIF prolyl hydroxylase inhibitor2024
Process for the preparation of crystalline ridinilazole using acid addition salt2022
Crystalline forms of valbenazine salts2021
Crystalline forms of valbenazine salts2021
Cabozantinib salts and their use as anti-cancer agents2019
Cabozantinib salts and their use as anti-cancer agents2019
Pharmaceutical composition containing crystalline macitentan2017
Crystalline forms of ponatinib hydrochloride2017
Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives2016
Process for the preparation of form III of vilazodone hydrochloride2015
Cyclic depsipeptides2015